Swiss say more data needed on AstraZeneca jab

Grapes could protect against sun damage, say dermatologists
3 February 2021
Unraveling the mystery of Gαo, a protein implicated in movement disorders
3 February 2021

Swiss say more data needed on AstraZeneca jab

Swiss regulators said Wednesday that data submitted by AstraZeneca were not sufficient for it to authorise use of the Anglo-Swedish firm’s COVID-19 vaccine and “new studies” were needed.

Comments are closed.